首页> American journal of kidney diseases : the official journal of the National Kidney Foundation> Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

导出 OA

翻译打印收藏纠错

第一作者： Patrick H,Pun

第一单位： Duke Clinical Research Institute, Durham, NC. Electronic address: patrick.pun@duke.edu.

作者： Patrick H,Pun ^[1] ; Sana M,Al-Khatib ^[2] ; Joo Yoon,Han ^[3] ; Rex,Edwards ^[2] ; Gust H,Bardy ^[3] ; J Thomas,Bigger ^[4] ; Alfred E,Buxton ^[5] ; Arthur J,Moss ^[6] ; Kerry L,Lee ^[2] ; Richard,Steinman ^[4] ; Paul,Dorian ^[7] ; Al,Hallstrom ^[3] ; Riccardo,Cappato ^[8] ; Alan H,Kadish ^[9] ; Peter J,Kudenchuk ^[3] ; Daniel B,Mark ^[2] ; Paul L,Hess ^[2] ; Lurdes Y T,Inoue ^[3] ; Gillian D,Sanders ^[2]

作者单位： Duke Clinical Research Institute, Durham, NC. Electronic address: patrick.pun@duke.edu. ^[1] Duke Clinical Research Institute, Durham, NC. ^[2] University of Washington, Seattle, WA. ^[3] Columbia University, New York, NY. ^[4] Beth Israel Deaconess Medical Center, Boston, MA. ^[5] University of Rochester, Rochester, NY. ^[6] University of Toronto, Toronto, ON, Canada. ^[7] I.R.C.C.S. Policlinico San Donato, Milan, Italy. ^[8] Northwestern Feinberg School of Medicine, Chicago, IL. ^[9]

关键词 Implantable cardioverter-defibrillator (ICD)chronic kidney disease (CKD)heart failure meta-analysis reduced ejection fraction sudden cardiac death